The mechanisms by which TP53, the most frequently mutated gene in human cancer, suppresses tumorigenesis remain unclear. p53 modulates various cellular processes, such as apoptosis and proliferation, which has led to distinct cellular mechanisms being proposed for p53-mediated tumor suppression in different contexts. Here, we asked whether during tumor suppression p53 might instead regulate a wide range of cellular processes. Analysis of mouse and human oncogene-expressing wild-type and p53-deficient cells in physiological oxygen conditions revealed that p53 loss concurrently impacts numerous distinct cellular processes, including apoptosis, genome stabilization, DNA repair, metabolism, migration, and invasion. Notably, some phenotypes were uncovered only in physiological oxygen. Transcriptomic analysis in this setting highlighted underappreciated functions modulated by p53, including actin dynamics. Collectively, these results suggest that p53 simultaneously governs diverse cellular processes during transformation suppression, an aspect of p53 function that would provide a clear rationale for its frequent inactivation in human cancer.
Skip Nav Destination
Close
Article navigation
2 November 2020
Article|
September 04 2020
p53 deficiency triggers dysregulation of diverse cellular processes in physiological oxygen
Liz J. Valente
,
Liz J. Valente
1
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
Search for other works by this author on:
Amy Tarangelo
,
Amy Tarangelo
2
Department of Biology, Stanford University, Stanford, CA
Search for other works by this author on:
Albert Mao Li
,
Albert Mao Li
1
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
Search for other works by this author on:
Marwan Naciri
,
Marwan Naciri
1
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
3École Normale Supérieure de Lyon, Université Claude Bernard Lyon I, Université de Lyon, Lyon, France
Search for other works by this author on:
Nitin Raj
,
Nitin Raj
1
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
Search for other works by this author on:
Anthony M. Boutelle
,
Anthony M. Boutelle
1
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
Search for other works by this author on:
Yang Li
,
Yang Li
1
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
Search for other works by this author on:
Stephano Spano Mello
,
Stephano Spano Mello
1
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
4Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY
Search for other works by this author on:
Kathryn Bieging-Rolett
,
Kathryn Bieging-Rolett
1
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
Search for other works by this author on:
Ralph J. DeBerardinis
,
Ralph J. DeBerardinis
5Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX
6Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX
Search for other works by this author on:
Jiangbin Ye
,
Jiangbin Ye
1
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
Search for other works by this author on:
Scott J. Dixon
,
Scott J. Dixon
2
Department of Biology, Stanford University, Stanford, CA
Search for other works by this author on:
Laura D. Attardi
Laura D. Attardi
1
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
7Department of Genetics, Stanford University School of Medicine, Stanford, CA
8Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
Search for other works by this author on:
Liz J. Valente
1
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
Amy Tarangelo
2
Department of Biology, Stanford University, Stanford, CA
Albert Mao Li
1
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
Marwan Naciri
1
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
3École Normale Supérieure de Lyon, Université Claude Bernard Lyon I, Université de Lyon, Lyon, France
Nitin Raj
1
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
Anthony M. Boutelle
1
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
Yang Li
1
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
Stephano Spano Mello
1
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
4Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY
Kathryn Bieging-Rolett
1
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
Ralph J. DeBerardinis
5Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX
6Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX
Jiangbin Ye
1
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
Scott J. Dixon
2
Department of Biology, Stanford University, Stanford, CA
Laura D. Attardi
1
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
7Department of Genetics, Stanford University School of Medicine, Stanford, CA
8Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
Correspondence to Laura D. Attardi: attardi@stanford.edu
Received:
August 29 2019
Revision Received:
June 17 2020
Accepted:
July 28 2020
Online Issn: 1540-8140
Print Issn: 0021-9525
© 2020 Valente et al.
2020
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
J Cell Biol (2020) 219 (11): e201908212.
Article history
Received:
August 29 2019
Revision Received:
June 17 2020
Accepted:
July 28 2020
Citation
Liz J. Valente, Amy Tarangelo, Albert Mao Li, Marwan Naciri, Nitin Raj, Anthony M. Boutelle, Yang Li, Stephano Spano Mello, Kathryn Bieging-Rolett, Ralph J. DeBerardinis, Jiangbin Ye, Scott J. Dixon, Laura D. Attardi; p53 deficiency triggers dysregulation of diverse cellular processes in physiological oxygen. J Cell Biol 2 November 2020; 219 (11): e201908212. doi: https://doi.org/10.1083/jcb.201908212
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your InstitutionAdvertisement
Advertisement